Concepts (324)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Vitamin D | 25 | 2018 | 189 | 3.210 |
Why?
|
| Vitamin D Deficiency | 17 | 2018 | 91 | 2.410 |
Why?
|
| Obesity | 29 | 2020 | 1152 | 2.170 |
Why?
|
| Aging | 26 | 2020 | 938 | 2.130 |
Why?
|
| Body Composition | 19 | 2020 | 388 | 1.710 |
Why?
|
| Weight Loss | 14 | 2020 | 457 | 1.700 |
Why?
|
| Mobility Limitation | 7 | 2017 | 220 | 1.350 |
Why?
|
| Aged | 76 | 2020 | 10544 | 1.290 |
Why?
|
| Dietary Proteins | 8 | 2020 | 55 | 1.150 |
Why?
|
| Overweight | 6 | 2018 | 263 | 1.150 |
Why?
|
| Life Style | 8 | 2020 | 407 | 1.140 |
Why?
|
| Body Mass Index | 24 | 2019 | 908 | 1.100 |
Why?
|
| European Continental Ancestry Group | 26 | 2018 | 1163 | 1.080 |
Why?
|
| Physical Fitness | 5 | 2012 | 133 | 1.050 |
Why?
|
| Exercise | 7 | 2019 | 679 | 1.050 |
Why?
|
| Polymorphism, Single Nucleotide | 21 | 2018 | 1066 | 1.020 |
Why?
|
| Female | 81 | 2020 | 20271 | 0.990 |
Why?
|
| Male | 78 | 2020 | 19650 | 0.980 |
Why?
|
| Caloric Restriction | 4 | 2019 | 101 | 0.950 |
Why?
|
| Diet | 7 | 2020 | 390 | 0.930 |
Why?
|
| Humans | 93 | 2020 | 32814 | 0.850 |
Why?
|
| Prospective Studies | 25 | 2020 | 2329 | 0.770 |
Why?
|
| Independent Living | 5 | 2020 | 105 | 0.720 |
Why?
|
| Diabetes Mellitus, Type 2 | 6 | 2018 | 1462 | 0.720 |
Why?
|
| Eating | 3 | 2017 | 74 | 0.720 |
Why?
|
| Accidental Falls | 4 | 2019 | 221 | 0.710 |
Why?
|
| Muscle Strength | 7 | 2020 | 157 | 0.690 |
Why?
|
| Motor Activity | 6 | 2015 | 327 | 0.660 |
Why?
|
| Genome-Wide Association Study | 15 | 2018 | 549 | 0.650 |
Why?
|
| Longevity | 1 | 2020 | 21 | 0.650 |
Why?
|
| Parathyroid Hormone | 5 | 2012 | 47 | 0.630 |
Why?
|
| Dietary Supplements | 6 | 2018 | 187 | 0.600 |
Why?
|
| African Continental Ancestry Group | 10 | 2018 | 363 | 0.590 |
Why?
|
| Disabled Persons | 2 | 2012 | 105 | 0.580 |
Why?
|
| Pennsylvania | 8 | 2018 | 86 | 0.540 |
Why?
|
| Tennessee | 8 | 2018 | 107 | 0.530 |
Why?
|
| Body Weight | 7 | 2020 | 301 | 0.510 |
Why?
|
| Amino Acids | 1 | 2017 | 46 | 0.510 |
Why?
|
| Middle Aged | 31 | 2020 | 12133 | 0.510 |
Why?
|
| Follow-Up Studies | 14 | 2019 | 2285 | 0.500 |
Why?
|
| Vitamins | 3 | 2015 | 73 | 0.490 |
Why?
|
| Nutrition Policy | 3 | 2020 | 35 | 0.490 |
Why?
|
| Muscle, Skeletal | 7 | 2019 | 524 | 0.480 |
Why?
|
| Homebound Persons | 1 | 2015 | 9 | 0.470 |
Why?
|
| Cholecalciferol | 1 | 2015 | 22 | 0.460 |
Why?
|
| Food Services | 1 | 2015 | 20 | 0.460 |
Why?
|
| Cohort Studies | 19 | 2018 | 1844 | 0.450 |
Why?
|
| Behavior Therapy | 1 | 2014 | 103 | 0.420 |
Why?
|
| Health Status | 8 | 2018 | 402 | 0.410 |
Why?
|
| Blood Glucose | 7 | 2019 | 494 | 0.400 |
Why?
|
| Activities of Daily Living | 5 | 2014 | 258 | 0.390 |
Why?
|
| Aged, 80 and over | 15 | 2020 | 4034 | 0.390 |
Why?
|
| African Americans | 9 | 2018 | 1424 | 0.390 |
Why?
|
| Feeding Behavior | 4 | 2017 | 158 | 0.380 |
Why?
|
| Genetic Loci | 6 | 2018 | 146 | 0.370 |
Why?
|
| Proportional Hazards Models | 7 | 2014 | 764 | 0.370 |
Why?
|
| Dairy Products | 2 | 2017 | 13 | 0.360 |
Why?
|
| Cross-Sectional Studies | 12 | 2018 | 1572 | 0.360 |
Why?
|
| Risk Factors | 18 | 2019 | 3976 | 0.360 |
Why?
|
| Incidence | 11 | 2019 | 1239 | 0.360 |
Why?
|
| Geriatric Assessment | 9 | 2019 | 388 | 0.350 |
Why?
|
| Depression | 1 | 2014 | 448 | 0.340 |
Why?
|
| Nutritional Status | 4 | 2014 | 78 | 0.340 |
Why?
|
| Hand Strength | 4 | 2018 | 101 | 0.340 |
Why?
|
| Insulin | 4 | 2015 | 367 | 0.340 |
Why?
|
| Randomized Controlled Trials as Topic | 5 | 2019 | 532 | 0.330 |
Why?
|
| Energy Intake | 7 | 2019 | 128 | 0.320 |
Why?
|
| Mortality | 4 | 2015 | 124 | 0.310 |
Why?
|
| Diet, Reducing | 4 | 2019 | 100 | 0.310 |
Why?
|
| Diet Surveys | 5 | 2019 | 55 | 0.300 |
Why?
|
| United States | 16 | 2019 | 4109 | 0.300 |
Why?
|
| Sarcopenia | 3 | 2019 | 66 | 0.290 |
Why?
|
| Retirement | 1 | 2008 | 13 | 0.290 |
Why?
|
| Linear Models | 7 | 2018 | 445 | 0.280 |
Why?
|
| Cognition | 4 | 2016 | 551 | 0.270 |
Why?
|
| Bone Density | 2 | 2019 | 203 | 0.270 |
Why?
|
| Muscular Atrophy | 1 | 2008 | 76 | 0.270 |
Why?
|
| Diabetes Mellitus | 2 | 2008 | 422 | 0.260 |
Why?
|
| Heart Diseases | 2 | 2018 | 116 | 0.260 |
Why?
|
| Longitudinal Studies | 7 | 2018 | 779 | 0.260 |
Why?
|
| Genotype | 8 | 2018 | 731 | 0.260 |
Why?
|
| Nutrition Assessment | 4 | 2011 | 54 | 0.260 |
Why?
|
| Gait | 3 | 2013 | 140 | 0.250 |
Why?
|
| Vegetables | 2 | 2010 | 39 | 0.240 |
Why?
|
| Fruit | 2 | 2010 | 56 | 0.240 |
Why?
|
| Adult | 16 | 2018 | 9569 | 0.240 |
Why?
|
| Ethnic Groups | 3 | 2017 | 474 | 0.230 |
Why?
|
| Pilot Projects | 2 | 2019 | 565 | 0.230 |
Why?
|
| Proteins | 3 | 2020 | 142 | 0.230 |
Why?
|
| Sex Factors | 7 | 2020 | 676 | 0.220 |
Why?
|
| Lung | 2 | 2018 | 265 | 0.220 |
Why?
|
| Thinness | 2 | 2015 | 33 | 0.200 |
Why?
|
| Confidence Intervals | 3 | 2009 | 148 | 0.200 |
Why?
|
| Diet, Mediterranean | 2 | 2014 | 31 | 0.200 |
Why?
|
| Alleles | 5 | 2014 | 253 | 0.190 |
Why?
|
| Cognition Disorders | 3 | 2014 | 370 | 0.190 |
Why?
|
| Meat | 2 | 2015 | 16 | 0.190 |
Why?
|
| Osteoporosis | 2 | 2019 | 71 | 0.180 |
Why?
|
| Adipose Tissue | 3 | 2011 | 349 | 0.180 |
Why?
|
| Frail Elderly | 2 | 2019 | 71 | 0.170 |
Why?
|
| Thigh | 2 | 2019 | 40 | 0.170 |
Why?
|
| Respiratory Function Tests | 2 | 2018 | 100 | 0.170 |
Why?
|
| Genetic Predisposition to Disease | 8 | 2018 | 835 | 0.170 |
Why?
|
| Nutritional Sciences | 1 | 2020 | 9 | 0.160 |
Why?
|
| Nutritional Physiological Phenomena | 1 | 2020 | 18 | 0.160 |
Why?
|
| Consensus Development Conferences as Topic | 1 | 2019 | 9 | 0.160 |
Why?
|
| Soft Tissue Injuries | 1 | 2019 | 20 | 0.160 |
Why?
|
| Risk Assessment | 5 | 2018 | 1461 | 0.160 |
Why?
|
| Chronic Disease | 2 | 2012 | 410 | 0.150 |
Why?
|
| Chi-Square Distribution | 4 | 2012 | 292 | 0.150 |
Why?
|
| Dietary Fats | 3 | 2014 | 109 | 0.140 |
Why?
|
| Age Factors | 5 | 2018 | 1197 | 0.140 |
Why?
|
| Vitamin K | 1 | 2018 | 9 | 0.140 |
Why?
|
| Disability Evaluation | 3 | 2019 | 238 | 0.140 |
Why?
|
| Random Allocation | 1 | 2019 | 229 | 0.140 |
Why?
|
| Clinical Trials as Topic | 1 | 2020 | 307 | 0.140 |
Why?
|
| Bone and Bones | 1 | 2019 | 94 | 0.140 |
Why?
|
| Lung Diseases | 1 | 2018 | 48 | 0.140 |
Why?
|
| Vesicular Transport Proteins | 1 | 2018 | 10 | 0.140 |
Why?
|
| Seafood | 1 | 2017 | 10 | 0.140 |
Why?
|
| Eicosapentaenoic Acid | 1 | 2017 | 29 | 0.140 |
Why?
|
| Docosahexaenoic Acids | 1 | 2017 | 20 | 0.140 |
Why?
|
| Inflammation | 2 | 2012 | 536 | 0.140 |
Why?
|
| Osteoarthritis, Knee | 1 | 2018 | 81 | 0.130 |
Why?
|
| Appetite | 1 | 2017 | 23 | 0.130 |
Why?
|
| Healthcare Disparities | 1 | 2019 | 178 | 0.130 |
Why?
|
| Genome, Human | 2 | 2018 | 132 | 0.130 |
Why?
|
| Heart | 1 | 2018 | 185 | 0.130 |
Why?
|
| Urinary Incontinence | 1 | 2017 | 48 | 0.130 |
Why?
|
| Absorptiometry, Photon | 4 | 2014 | 136 | 0.130 |
Why?
|
| Walking | 3 | 2013 | 210 | 0.130 |
Why?
|
| Genetics, Population | 1 | 2017 | 31 | 0.130 |
Why?
|
| Lower Extremity | 1 | 2018 | 107 | 0.130 |
Why?
|
| Dietary Carbohydrates | 2 | 2014 | 23 | 0.130 |
Why?
|
| Mendelian Randomization Analysis | 2 | 2014 | 17 | 0.130 |
Why?
|
| Prevalence | 4 | 2018 | 1002 | 0.130 |
Why?
|
| Exercise Therapy | 2 | 2019 | 271 | 0.120 |
Why?
|
| Membrane Proteins | 2 | 2018 | 251 | 0.120 |
Why?
|
| Odds Ratio | 4 | 2017 | 467 | 0.120 |
Why?
|
| Time Factors | 5 | 2015 | 2183 | 0.120 |
Why?
|
| Health Behavior | 3 | 2014 | 234 | 0.120 |
Why?
|
| Meat Products | 1 | 2015 | 3 | 0.120 |
Why?
|
| Hyperinsulinism | 1 | 2015 | 13 | 0.120 |
Why?
|
| Phenotype | 5 | 2015 | 638 | 0.120 |
Why?
|
| Hip Fractures | 2 | 2012 | 30 | 0.120 |
Why?
|
| Stroke Volume | 1 | 2018 | 370 | 0.110 |
Why?
|
| Insulin-Secreting Cells | 1 | 2015 | 53 | 0.110 |
Why?
|
| Epistasis, Genetic | 1 | 2015 | 44 | 0.110 |
Why?
|
| Hyperglycemia | 1 | 2015 | 81 | 0.110 |
Why?
|
| Single-Blind Method | 1 | 2015 | 195 | 0.110 |
Why?
|
| Coffea | 1 | 2014 | 1 | 0.110 |
Why?
|
| Oxidoreductases Acting on CH-CH Group Donors | 1 | 2014 | 9 | 0.110 |
Why?
|
| Feasibility Studies | 1 | 2015 | 308 | 0.110 |
Why?
|
| Antidepressive Agents | 1 | 2014 | 74 | 0.110 |
Why?
|
| Hearing Loss | 1 | 2014 | 26 | 0.110 |
Why?
|
| Genetic Variation | 2 | 2012 | 246 | 0.110 |
Why?
|
| Apolipoprotein E4 | 1 | 2014 | 57 | 0.110 |
Why?
|
| Health Surveys | 2 | 2011 | 200 | 0.110 |
Why?
|
| Phosphoric Monoester Hydrolases | 1 | 2013 | 11 | 0.100 |
Why?
|
| Adiposity | 2 | 2012 | 198 | 0.100 |
Why?
|
| Fasting | 2 | 2012 | 94 | 0.100 |
Why?
|
| Muscle Weakness | 1 | 2014 | 36 | 0.100 |
Why?
|
| Health Education | 1 | 2014 | 162 | 0.100 |
Why?
|
| Predictive Value of Tests | 3 | 2014 | 888 | 0.100 |
Why?
|
| Nutrition Surveys | 5 | 2013 | 150 | 0.100 |
Why?
|
| Homozygote | 2 | 2010 | 58 | 0.100 |
Why?
|
| PPAR gamma | 2 | 2011 | 44 | 0.100 |
Why?
|
| Calcium, Dietary | 1 | 2013 | 23 | 0.100 |
Why?
|
| Trace Elements | 1 | 2013 | 7 | 0.100 |
Why?
|
| Carbohydrate Metabolism | 1 | 2012 | 17 | 0.100 |
Why?
|
| Lipoprotein Lipase | 1 | 2012 | 14 | 0.100 |
Why?
|
| Magnesium | 1 | 2013 | 30 | 0.100 |
Why?
|
| Receptors, Calcitriol | 1 | 2012 | 9 | 0.100 |
Why?
|
| Hyperparathyroidism | 1 | 2012 | 9 | 0.100 |
Why?
|
| Vitamin B 12 Deficiency | 1 | 2012 | 5 | 0.090 |
Why?
|
| Gene Frequency | 3 | 2018 | 220 | 0.090 |
Why?
|
| Seasons | 4 | 2015 | 89 | 0.090 |
Why?
|
| Insulin Resistance | 1 | 2015 | 469 | 0.090 |
Why?
|
| Homeostasis | 1 | 2012 | 135 | 0.090 |
Why?
|
| Linkage Disequilibrium | 4 | 2013 | 185 | 0.090 |
Why?
|
| Urban Population | 1 | 2012 | 93 | 0.090 |
Why?
|
| Heart Failure | 1 | 2018 | 695 | 0.090 |
Why?
|
| Peripheral Nervous System Diseases | 1 | 2012 | 51 | 0.090 |
Why?
|
| Knee | 1 | 2011 | 31 | 0.090 |
Why?
|
| Socioeconomic Factors | 2 | 2014 | 436 | 0.090 |
Why?
|
| Cation Transport Proteins | 1 | 2011 | 24 | 0.090 |
Why?
|
| Lipids | 1 | 2012 | 229 | 0.090 |
Why?
|
| Zinc | 1 | 2011 | 31 | 0.090 |
Why?
|
| Pain Measurement | 1 | 2012 | 356 | 0.090 |
Why?
|
| Reference Values | 1 | 2011 | 238 | 0.090 |
Why?
|
| Calcium | 1 | 2013 | 323 | 0.090 |
Why?
|
| Anthropometry | 2 | 2014 | 84 | 0.080 |
Why?
|
| Case-Control Studies | 3 | 2018 | 877 | 0.080 |
Why?
|
| Thiazolidinediones | 1 | 2011 | 45 | 0.080 |
Why?
|
| Multicenter Studies as Topic | 1 | 2011 | 111 | 0.080 |
Why?
|
| Quality of Life | 2 | 2019 | 962 | 0.080 |
Why?
|
| MicroRNAs | 1 | 2012 | 188 | 0.080 |
Why?
|
| Fractures, Bone | 1 | 2012 | 162 | 0.080 |
Why?
|
| Body Fat Distribution | 1 | 2010 | 32 | 0.080 |
Why?
|
| Resistance Training | 1 | 2011 | 77 | 0.080 |
Why?
|
| Hypertension | 2 | 2014 | 976 | 0.080 |
Why?
|
| Europe | 3 | 2017 | 83 | 0.080 |
Why?
|
| Inflammation Mediators | 1 | 2010 | 102 | 0.080 |
Why?
|
| Hypoglycemic Agents | 1 | 2011 | 180 | 0.080 |
Why?
|
| Energy Metabolism | 1 | 2010 | 155 | 0.070 |
Why?
|
| Physical Endurance | 1 | 2008 | 35 | 0.070 |
Why?
|
| Age Distribution | 1 | 2009 | 201 | 0.070 |
Why?
|
| Health Status Disparities | 1 | 2009 | 134 | 0.070 |
Why?
|
| Oxygen Consumption | 2 | 2019 | 150 | 0.070 |
Why?
|
| Logistic Models | 2 | 2011 | 783 | 0.070 |
Why?
|
| Hospitalization | 1 | 2010 | 488 | 0.070 |
Why?
|
| Arteriosclerosis | 2 | 2005 | 124 | 0.070 |
Why?
|
| Patient Selection | 1 | 2008 | 281 | 0.060 |
Why?
|
| Exercise Test | 2 | 2019 | 223 | 0.060 |
Why?
|
| Atherosclerosis | 2 | 2013 | 788 | 0.060 |
Why?
|
| Sex Distribution | 1 | 2007 | 185 | 0.060 |
Why?
|
| Forced Expiratory Volume | 2 | 2018 | 89 | 0.060 |
Why?
|
| Prognosis | 3 | 2018 | 1545 | 0.060 |
Why?
|
| Fibroblast Growth Factors | 2 | 2018 | 35 | 0.060 |
Why?
|
| Cardiovascular Diseases | 1 | 2013 | 1140 | 0.060 |
Why?
|
| Regression Analysis | 2 | 2018 | 288 | 0.060 |
Why?
|
| Multivariate Analysis | 2 | 2018 | 682 | 0.050 |
Why?
|
| Neuropsychological Tests | 2 | 2016 | 363 | 0.050 |
Why?
|
| Adaptor Proteins, Signal Transducing | 2 | 2014 | 65 | 0.050 |
Why?
|
| Retrospective Studies | 2 | 2008 | 3705 | 0.050 |
Why?
|
| Quantitative Trait Loci | 2 | 2013 | 141 | 0.050 |
Why?
|
| Dietary Fiber | 1 | 2002 | 20 | 0.050 |
Why?
|
| Risk | 2 | 2014 | 315 | 0.050 |
Why?
|
| Cause of Death | 2 | 2012 | 240 | 0.040 |
Why?
|
| Biomass | 1 | 2020 | 3 | 0.040 |
Why?
|
| Abdominal Fat | 2 | 2011 | 47 | 0.040 |
Why?
|
| Cluster Analysis | 2 | 2011 | 126 | 0.040 |
Why?
|
| Smoking | 2 | 2018 | 531 | 0.040 |
Why?
|
| Subcutaneous Fat | 2 | 2011 | 49 | 0.040 |
Why?
|
| Muscle Development | 1 | 2020 | 49 | 0.040 |
Why?
|
| Muscles | 1 | 2020 | 63 | 0.040 |
Why?
|
| National Institute on Aging (U.S.) | 1 | 2019 | 8 | 0.040 |
Why?
|
| Maryland | 1 | 2019 | 28 | 0.040 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2014 | 622 | 0.040 |
Why?
|
| Residence Characteristics | 2 | 2012 | 197 | 0.040 |
Why?
|
| Tomography | 1 | 2019 | 5 | 0.040 |
Why?
|
| Hip | 1 | 2019 | 15 | 0.040 |
Why?
|
| Fatigue | 1 | 2019 | 83 | 0.040 |
Why?
|
| Survival Analysis | 2 | 2011 | 486 | 0.040 |
Why?
|
| Young Adult | 2 | 2018 | 2734 | 0.040 |
Why?
|
| Weight Gain | 1 | 2019 | 112 | 0.040 |
Why?
|
| Molecular Epidemiology | 1 | 2018 | 20 | 0.040 |
Why?
|
| Geriatrics | 1 | 2019 | 85 | 0.040 |
Why?
|
| Vital Capacity | 1 | 2018 | 42 | 0.040 |
Why?
|
| Receptors, Retinoic Acid | 1 | 2018 | 9 | 0.040 |
Why?
|
| Femur | 1 | 2019 | 79 | 0.040 |
Why?
|
| Hispanic Americans | 2 | 2018 | 930 | 0.040 |
Why?
|
| Lumbar Vertebrae | 1 | 2019 | 110 | 0.030 |
Why?
|
| Exercise Tolerance | 1 | 2019 | 120 | 0.030 |
Why?
|
| Amidohydrolases | 1 | 2018 | 8 | 0.030 |
Why?
|
| Health Services for the Aged | 1 | 2018 | 25 | 0.030 |
Why?
|
| Myosin-Light-Chain Phosphatase | 1 | 2017 | 1 | 0.030 |
Why?
|
| Actins | 1 | 2017 | 51 | 0.030 |
Why?
|
| Genomics | 1 | 2018 | 88 | 0.030 |
Why?
|
| Autoimmune Diseases | 1 | 2018 | 49 | 0.030 |
Why?
|
| Posture | 1 | 2017 | 56 | 0.030 |
Why?
|
| Postural Balance | 1 | 2017 | 180 | 0.030 |
Why?
|
| Publication Bias | 1 | 2015 | 8 | 0.030 |
Why?
|
| Genetic Association Studies | 1 | 2015 | 148 | 0.030 |
Why?
|
| Vitamin D-Binding Protein | 1 | 2015 | 9 | 0.030 |
Why?
|
| Severity of Illness Index | 1 | 2018 | 881 | 0.030 |
Why?
|
| Cytochrome P-450 CYP1A2 | 1 | 2014 | 3 | 0.030 |
Why?
|
| Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 2014 | 2 | 0.030 |
Why?
|
| Brain-Derived Neurotrophic Factor | 1 | 2014 | 37 | 0.030 |
Why?
|
| Asian Continental Ancestry Group | 1 | 2014 | 108 | 0.030 |
Why?
|
| 25-Hydroxyvitamin D 2 | 1 | 2014 | 1 | 0.030 |
Why?
|
| Georgia | 1 | 2014 | 14 | 0.030 |
Why?
|
| Calcifediol | 1 | 2014 | 8 | 0.030 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2013 | 154 | 0.030 |
Why?
|
| National Institutes of Health (U.S.) | 1 | 2013 | 29 | 0.020 |
Why?
|
| Metagenomics | 1 | 2013 | 3 | 0.020 |
Why?
|
| North America | 1 | 2013 | 30 | 0.020 |
Why?
|
| TRPM Cation Channels | 1 | 2013 | 4 | 0.020 |
Why?
|
| Steroid Hydroxylases | 1 | 2012 | 2 | 0.020 |
Why?
|
| 25-Hydroxyvitamin D3 1-alpha-Hydroxylase | 1 | 2012 | 5 | 0.020 |
Why?
|
| Epithelial Cells | 1 | 2013 | 129 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2014 | 576 | 0.020 |
Why?
|
| Medicare | 1 | 2014 | 213 | 0.020 |
Why?
|
| Meta-Analysis as Topic | 1 | 2012 | 46 | 0.020 |
Why?
|
| Genetic Markers | 1 | 2012 | 125 | 0.020 |
Why?
|
| Receptors, Cell Surface | 1 | 2012 | 69 | 0.020 |
Why?
|
| Chromosome Mapping | 1 | 2013 | 193 | 0.020 |
Why?
|
| Cholesterol, HDL | 1 | 2012 | 175 | 0.020 |
Why?
|
| Lipid Metabolism | 1 | 2012 | 105 | 0.020 |
Why?
|
| Triglycerides | 1 | 2012 | 228 | 0.020 |
Why?
|
| Evidence-Based Medicine | 1 | 2013 | 215 | 0.020 |
Why?
|
| Child | 1 | 2018 | 2478 | 0.020 |
Why?
|
| Distance Perception | 1 | 2011 | 3 | 0.020 |
Why?
|
| Judgment | 1 | 2011 | 12 | 0.020 |
Why?
|
| Continental Population Groups | 1 | 2013 | 236 | 0.020 |
Why?
|
| Intention | 1 | 2011 | 32 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2012 | 459 | 0.020 |
Why?
|
| Arm | 1 | 2011 | 39 | 0.020 |
Why?
|
| Choristoma | 1 | 2011 | 14 | 0.020 |
Why?
|
| Organ Size | 1 | 2011 | 219 | 0.020 |
Why?
|
| Psychomotor Performance | 1 | 2011 | 99 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 4 | 1 | 2010 | 11 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 11 | 1 | 2010 | 24 | 0.020 |
Why?
|
| Immunoassay | 1 | 2010 | 16 | 0.020 |
Why?
|
| International Cooperation | 1 | 2010 | 30 | 0.020 |
Why?
|
| Canada | 1 | 2010 | 64 | 0.020 |
Why?
|
| Heterozygote | 1 | 2010 | 61 | 0.020 |
Why?
|
| Gene Expression Regulation | 1 | 2012 | 475 | 0.020 |
Why?
|
| Adipokines | 1 | 2010 | 16 | 0.020 |
Why?
|
| Adolescent | 1 | 2018 | 3640 | 0.020 |
Why?
|
| Diet, Fat-Restricted | 1 | 2010 | 31 | 0.020 |
Why?
|
| Self Disclosure | 1 | 2010 | 22 | 0.020 |
Why?
|
| Water | 1 | 2010 | 61 | 0.020 |
Why?
|
| Staining and Labeling | 1 | 2010 | 57 | 0.020 |
Why?
|
| Baltimore | 1 | 2009 | 50 | 0.020 |
Why?
|
| Waist Circumference | 1 | 2009 | 92 | 0.020 |
Why?
|
| Polymorphism, Genetic | 1 | 2010 | 183 | 0.020 |
Why?
|
| Myocardial Infarction | 1 | 2012 | 483 | 0.020 |
Why?
|
| Combined Modality Therapy | 1 | 2008 | 563 | 0.020 |
Why?
|
| Postmenopause | 1 | 2008 | 427 | 0.020 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2011 | 949 | 0.010 |
Why?
|
| Neoplasms | 1 | 2012 | 762 | 0.010 |
Why?
|
| Alcohol Drinking | 1 | 2007 | 256 | 0.010 |
Why?
|
| North Carolina | 1 | 2002 | 1546 | 0.010 |
Why?
|